Antibiotic Resistance (ABR) Panel

An antibiotic PCR panel is an essential diagnostic tool harnessing the power of polymerase chain reaction (PCR) to swiftly and accurately detect antibiotic-resistant pathogens in clinical specimens. In contrast to conventional culture-based methods, this molecular assay provides a rapid and precise means of identifying the culprits behind antibiotic-resistant infections. This ability is pivotal in guiding healthcare providers to select the most effective antibiotics, especially in the face of rising antibiotic resistance.

Much like its respiratory counterpart, the antibiotic PCR panel excels at uncovering the specific pathogens causing infections and can identify co-infections, where multiple antibiotic-resistant pathogens might simultaneously contribute to the disease. Different iterations of the antibiotic PCR panel cater to a variety of antibiotic-resistant pathogens. For example, the broad-spectrum antibiotic panel (BSAP) targets a comprehensive array of antibiotic-resistant bacteria, including formidable foes like methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamase (ESBL) producers, and carbapenem-resistant Enterobacteriaceae (CRE). Meanwhile, the multidrug-resistant pathogen panel (MDRPP) extends its reach to cover an extensive roster of antibiotic-resistant pathogens, both bacterial and fungal, capable of withstanding multiple classes of antibiotics. With rapid results and precision at its core, the antibiotic PCR panel contributes significantly to better patient outcomes and the fight against antibiotic resistance.